Peringatan Keamanan

Convulsions

Exemestane

DB00990

small molecule approved investigational

Deskripsi

Exemestane is an oral steroidal aromatase inhibitor used in the adjuvant treatment of hormonally-responsive (also called hormone-receptor-positive, estrogen-responsive) breast cancer in postmenopausal women. It irreversibly binds to the active site of the enzyme resulting in permanent inhibition.

Struktur Molekul 2D

Berat 296.4034
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 24 hours
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

42%

Metabolisme

Hepatic

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Makanan

1 Data
  • 1. Take with food. The manufacturer recommends administration following a meal.

Interaksi Obat

175 Data
Diethylstilbestrol The therapeutic efficacy of Exemestane can be decreased when used in combination with Diethylstilbestrol.
Chlorotrianisene The therapeutic efficacy of Exemestane can be decreased when used in combination with Chlorotrianisene.
Conjugated estrogens The therapeutic efficacy of Exemestane can be decreased when used in combination with Conjugated estrogens.
Estrone The therapeutic efficacy of Exemestane can be decreased when used in combination with Estrone.
Estradiol The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol.
Dienestrol The therapeutic efficacy of Exemestane can be decreased when used in combination with Dienestrol.
Ethinylestradiol The therapeutic efficacy of Exemestane can be decreased when used in combination with Ethinylestradiol.
Mestranol The therapeutic efficacy of Exemestane can be decreased when used in combination with Mestranol.
Estriol The therapeutic efficacy of Exemestane can be decreased when used in combination with Estriol.
Estrone sulfate The therapeutic efficacy of Exemestane can be decreased when used in combination with Estrone sulfate.
Quinestrol The therapeutic efficacy of Exemestane can be decreased when used in combination with Quinestrol.
Hexestrol The therapeutic efficacy of Exemestane can be decreased when used in combination with Hexestrol.
Tibolone The therapeutic efficacy of Exemestane can be decreased when used in combination with Tibolone.
Synthetic Conjugated Estrogens, A The therapeutic efficacy of Exemestane can be decreased when used in combination with Synthetic Conjugated Estrogens, A.
Synthetic Conjugated Estrogens, B The therapeutic efficacy of Exemestane can be decreased when used in combination with Synthetic Conjugated Estrogens, B.
Polyestradiol phosphate The therapeutic efficacy of Exemestane can be decreased when used in combination with Polyestradiol phosphate.
Esterified estrogens The therapeutic efficacy of Exemestane can be decreased when used in combination with Esterified estrogens.
Zeranol The therapeutic efficacy of Exemestane can be decreased when used in combination with Zeranol.
Equol The therapeutic efficacy of Exemestane can be decreased when used in combination with Equol.
Promestriene The therapeutic efficacy of Exemestane can be decreased when used in combination with Promestriene.
Methallenestril The therapeutic efficacy of Exemestane can be decreased when used in combination with Methallenestril.
Epimestrol The therapeutic efficacy of Exemestane can be decreased when used in combination with Epimestrol.
Moxestrol The therapeutic efficacy of Exemestane can be decreased when used in combination with Moxestrol.
Estradiol acetate The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol acetate.
Estradiol benzoate The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol benzoate.
Estradiol cypionate The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol cypionate.
Estradiol valerate The therapeutic efficacy of Exemestane can be decreased when used in combination with Estradiol valerate.
Biochanin A The therapeutic efficacy of Exemestane can be decreased when used in combination with Biochanin A.
Formononetin The therapeutic efficacy of Exemestane can be decreased when used in combination with Formononetin.
Estetrol The therapeutic efficacy of Exemestane can be decreased when used in combination with Estetrol.
Methadone The serum concentration of Methadone can be increased when it is combined with Exemestane.
Pitolisant The serum concentration of Exemestane can be decreased when it is combined with Pitolisant.
Metreleptin The metabolism of Exemestane can be increased when combined with Metreleptin.
Cenobamate The serum concentration of Exemestane can be decreased when it is combined with Cenobamate.
Ritonavir The serum concentration of Exemestane can be increased when it is combined with Ritonavir.
Haloperidol The serum concentration of Haloperidol can be increased when it is combined with Exemestane.
Tucatinib The metabolism of Tucatinib can be decreased when combined with Exemestane.
Abametapir The serum concentration of Exemestane can be increased when it is combined with Abametapir.
Satralizumab The serum concentration of Exemestane can be decreased when it is combined with Satralizumab.
Sotorasib The serum concentration of Exemestane can be decreased when it is combined with Sotorasib.
Cyclosporine The metabolism of Exemestane can be decreased when combined with Cyclosporine.
Fluvoxamine The metabolism of Exemestane can be decreased when combined with Fluvoxamine.
Fluconazole The metabolism of Exemestane can be decreased when combined with Fluconazole.
Erythromycin The serum concentration of Exemestane can be increased when it is combined with Erythromycin.
Ziprasidone The metabolism of Exemestane can be decreased when combined with Ziprasidone.
Isradipine The metabolism of Exemestane can be decreased when combined with Isradipine.
Diltiazem The metabolism of Exemestane can be decreased when combined with Diltiazem.
Clozapine The metabolism of Exemestane can be decreased when combined with Clozapine.
Ciprofloxacin The metabolism of Exemestane can be decreased when combined with Ciprofloxacin.
Nicardipine The metabolism of Exemestane can be decreased when combined with Nicardipine.
Verapamil The metabolism of Exemestane can be decreased when combined with Verapamil.
Aprepitant The metabolism of Exemestane can be decreased when combined with Aprepitant.
Isoniazid The metabolism of Exemestane can be decreased when combined with Isoniazid.
Primaquine The metabolism of Exemestane can be decreased when combined with Primaquine.
Miconazole The metabolism of Exemestane can be decreased when combined with Miconazole.
Fusidic acid The metabolism of Exemestane can be decreased when combined with Fusidic acid.
Zimelidine The metabolism of Exemestane can be decreased when combined with Zimelidine.
Dronedarone The metabolism of Exemestane can be decreased when combined with Dronedarone.
Milnacipran The metabolism of Exemestane can be decreased when combined with Milnacipran.
Simeprevir The metabolism of Exemestane can be decreased when combined with Simeprevir.
Isavuconazonium The metabolism of Exemestane can be decreased when combined with Isavuconazonium.
Desvenlafaxine The metabolism of Exemestane can be decreased when combined with Desvenlafaxine.
Nilvadipine The metabolism of Exemestane can be decreased when combined with Nilvadipine.
Seproxetine The metabolism of Exemestane can be decreased when combined with Seproxetine.
Linagliptin The metabolism of Exemestane can be decreased when combined with Linagliptin.
Indalpine The metabolism of Exemestane can be decreased when combined with Indalpine.
Netupitant The metabolism of Exemestane can be decreased when combined with Netupitant.
Barnidipine The metabolism of Exemestane can be decreased when combined with Barnidipine.
Benidipine The metabolism of Exemestane can be decreased when combined with Benidipine.
Venetoclax The metabolism of Exemestane can be decreased when combined with Venetoclax.
Isavuconazole The metabolism of Exemestane can be decreased when combined with Isavuconazole.
Fosnetupitant The metabolism of Exemestane can be decreased when combined with Fosnetupitant.
Berotralstat The metabolism of Exemestane can be decreased when combined with Berotralstat.
Voriconazole The metabolism of Exemestane can be decreased when combined with Voriconazole.
Danazol The metabolism of Exemestane can be decreased when combined with Danazol.
Nelfinavir The metabolism of Exemestane can be decreased when combined with Nelfinavir.
Indinavir The metabolism of Exemestane can be decreased when combined with Indinavir.
Terfenadine The metabolism of Exemestane can be decreased when combined with Terfenadine.
Efavirenz The metabolism of Exemestane can be decreased when combined with Efavirenz.
Ergotamine The metabolism of Exemestane can be decreased when combined with Ergotamine.
Amprenavir The metabolism of Exemestane can be decreased when combined with Amprenavir.
Delavirdine The metabolism of Exemestane can be decreased when combined with Delavirdine.
Methimazole The metabolism of Exemestane can be decreased when combined with Methimazole.
Conivaptan The metabolism of Exemestane can be decreased when combined with Conivaptan.
Tipranavir The metabolism of Exemestane can be decreased when combined with Tipranavir.
Telithromycin The metabolism of Exemestane can be decreased when combined with Telithromycin.
Ketoconazole The metabolism of Exemestane can be decreased when combined with Ketoconazole.
Atazanavir The metabolism of Exemestane can be decreased when combined with Atazanavir.
Amiodarone The metabolism of Exemestane can be decreased when combined with Amiodarone.
Nefazodone The metabolism of Exemestane can be decreased when combined with Nefazodone.
Itraconazole The metabolism of Exemestane can be decreased when combined with Itraconazole.
Clarithromycin The metabolism of Exemestane can be decreased when combined with Clarithromycin.
Saquinavir The metabolism of Exemestane can be decreased when combined with Saquinavir.
Posaconazole The metabolism of Exemestane can be decreased when combined with Posaconazole.
Darunavir The metabolism of Exemestane can be decreased when combined with Darunavir.
Lopinavir The metabolism of Exemestane can be decreased when combined with Lopinavir.
Ditiocarb The metabolism of Exemestane can be decreased when combined with Ditiocarb.
Nilotinib The metabolism of Exemestane can be decreased when combined with Nilotinib.
Telaprevir The metabolism of Exemestane can be decreased when combined with Telaprevir.
Lonafarnib The metabolism of Exemestane can be decreased when combined with Lonafarnib.

Target Protein

Aromatase CYP19A1

Referensi & Sumber

Synthesis reference: Kevin Kunnen, Nathan W. Stehle, Scot W. Weis, John M. Pascone, Richard J. Pariza, Scott G. Van Ornum, Paul Zizelman, "Exemestane and Its Intermediates and Methods of Making the Same." U.S. Patent US20080234505, issued September 25, 2008.
Artikel (PubMed)
  • PMID: 17307102
    Coombes RC, Kilburn LS, Snowdon CF, Paridaens R, Coleman RE, Jones SE, Jassem J, Van de Velde CJ, Delozier T, Alvarez I, Del Mastro L, Ortmann O, Diedrich K, Coates AS, Bajetta E, Holmberg SB, Dodwell D, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Forbes J, Castiglione M, Stuart N, Stewart A, Fallowfield LJ, Bertelli G, Hall E, Bogle RG, Carpentieri M, Colajori E, Subar M, Ireland E, Bliss JM: Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet. 2007 Feb 17;369(9561):559-70.
  • PMID: 19436613
    Robinson A: A review of the use of exemestane in early breast cancer. Ther Clin Risk Manag. 2009 Feb;5(1):91-8. Epub 2009 Mar 26.
  • PMID: 19337436
    Untch M, Jackisch C: Exemestane in early breast cancer: a review. Ther Clin Risk Manag. 2008 Dec;4(6):1295-304.
  • PMID: 20360896
    Abrial C, Durando X, Mouret-Reynier MA, Thivat E, Bayet-Robert M, Nayl B, Dubray P, Pomel C, Chollet P, Penault-Llorca F: Role of neo-adjuvant hormonal therapy in the treatment of breast cancer: a review of clinical trials. Int J Gen Med. 2009 Jul 30;2:129-40.
  • PMID: 18728707
    Nabholtz JM: Long-term safety of aromatase inhibitors in the treatment of breast cancer. Ther Clin Risk Manag. 2008 Feb;4(1):189-204.

Contoh Produk & Brand

Produk: 25 • International brands: 1
Produk
  • Act Exemestane
    Tablet • 25 mg • Oral • Canada • Approved
  • Apo-exemestane
    Tablet • 25 mg • Oral • Canada • Generic • Approved
  • Aromasin
    Tablet • 25 mg/1 • Oral • US • Approved
  • Aromasin
    Tablet • 25 mg/1 • Oral • US • Approved
  • Aromasin
    Tablet • 25 mg • Oral • Canada • Approved
  • Exemestane
    Tablet • 25 mg/1 • Oral • US • Generic • Approved
  • Exemestane
    Tablet, sugar coated • 25 mg/1 • Oral • US • Generic • Approved
  • Exemestane
    Tablet • 25 mg/1 • Oral • US • Generic • Approved
Menampilkan 8 dari 25 produk.
International Brands
  • Exemestance

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul